Story perspectives
Sen. Scott's CLEAR LABELS Act Boosts Drug Transparency
1/30/2026
30 2
1 of 1
Story summary
- Sen. Rick Scott (R-Fla.) introduced the CLEAR LABELS Act requiring prescription drug labels to disclose original generic drug manufacturers.
- The measure aims to boost transparency, address safety concerns about medicines from China and India, and support American jobs.
- The bill aligns with a Senate labeling hearing.
- It follows a bipartisan report directed by Sen. Kirsten Gillibrand (D-N.Y.) urging the prioritization of American-made active pharmaceutical ingredients.
